Terns Pharmaceuticals Ownership | Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals Ownership Summary

Terns Pharmaceuticals is owned by 90.74% institutional investors, 0.30% insiders, and 8.97% retail investors. Soleus capital management is the largest institutional shareholder, holding 8.92% of TERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.43% of its assets in Terns Pharmaceuticals shares.

TERN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Terns Pharmaceuticals	90.74%	0.30%	8.97%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Soleus capital management	8.17M	8.92%	$30.46M
Orbimed advisors	7.56M	8.26%	$28.21M
Deep track capital, lp	7.50M	8.18%	$27.96M
Vivo capital	6.90M	7.53%	$25.72M
Schonfeld strategic advisors	4.75M	6.11%	$26.32M
Blackrock funding, inc. /de	5.47M	5.97%	$20.40M
Blackrock	4.12M	5.53%	$28.06M
Vanguard group	3.87M	4.97%	$21.44M
Nuveen asset management	2.63M	3.38%	$14.59M
Candriam s.c.a.	2.37M	2.59%	$8.83M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Superstring capital management lp	1.29M	5.68%	$4.80M
Vivo capital	6.90M	2.63%	$25.72M
Acuta capital partners	463.86K	2.42%	$1.73M
Soleus capital management	8.17M	2.02%	$30.46M
Timessquare capital management	621.64K	1.45%	$92.18M
Robeco schweiz	411.27K	1.17%	$60.99M
Deep track capital, lp	7.50M	0.90%	$27.96M
Orbimed advisors	7.56M	0.71%	$28.21M
Parkman healthcare partners	817.81K	0.35%	$3.05M
Integral health asset management	700.00K	0.24%	$2.61M

Top Buyers

Holder	Shares	% Assets	Change
Deep track capital, lp	7.50M	0.90%	1.92M
Schonfeld strategic advisors	4.75M	0.15%	1.46M
Adage capital partners gp	1.28M	0.01%	1.28M
Norges bank	849.39K	0.00%	849.39K
Blackrock	4.12M	0.00%	804.98K

Top Sellers

Holder	Shares	% Assets	Change
Avidity partners management lp	-	-	-2.13M
Janus henderson group	-	-	-2.00M
Octagon capital advisors lp	-	-	-1.36M
Suvretta capital management	-	-	-1.36M
Great point partners	-	-	-1.15M

New Positions

Holder	Shares	% Assets	Change	Value
Adage capital partners gp	1.28M	0.01%	1.28M	$4.77M
Norges bank	849.39K	0.00%	849.39K	$4.71M
Bnp paribas arbitrage, snc	224.26K	0.00%	224.26K	$1.24M
Alps advisors	47.16K	0.00%	47.16K	$175.89K
Dld asset management, lp	37.05K	0.01%	37.05K	$138.19K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-9.00
True wealth design	-11.00
Pnc financial services group	-17.00
Capital performance advisors llp	-23.00
Farther finance advisors	-27.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	129	-7.19%	83,090,778	-0.02%	90	1.10%	71	1.43%	30	-23.08%
Mar 31, 2025	139	-13.66%	83,111,324	-3.50%	90	0.74%	70	-33.33%	39	21.88%
Dec 31, 2024	149	-9.70%	81,944,156	3.09%	105	1.01%	94	-8.74%	31	-18.42%
Sep 30, 2024	165	17.86%	79,491,270	19.38%	102	1.28%	103	8.42%	38	65.22%
Jun 30, 2024	140	19.66%	66,584,833	5.52%	89	1.24%	95	48.44%	23	-28.13%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.12M	2.43%	-47.20K
Vanguard US Total Market Shares ETF	2.09M	2.39%	792.70K
iShares Russell 2000 ETF	1.73M	1.98%	-32.97K
Belfius Equities Cure C Cap	1.29M	1.47%	-
Fidelity Select Biotechnology	1.09M	1.29%	1.09M
Candriam Eqs L Biotech C USD Cap	1.08M	1.24%	-
CREF Stock R1	1.08M	1.23%	-160.00K
T. Rowe Price New Horizons	1.04M	1.23%	-
US Small-Cap Growth II Equity Comp	1.04M	1.23%	529.45K
Fidelity Small Cap Growth	877.41K	1.04%	-1.09M

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 01, 2025	Kuriakose Emil	Chief Medical Officer	Sell	$3.64K
Jun 27, 2025	Gengos Andrew	Chief Financial Officer	Buy	$19.65K
Jun 27, 2025	Gengos Andrew	Chief Financial Officer	Buy	$19.63K
Jun 25, 2025	Burroughs Amy L.	Chief Executive Officer	Buy	$90.23K
Jun 13, 2025	Gengos Andrew	Chief Financial Officer	Buy	$18.60K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	1
2025 Q2	6	1
2025 Q1	-	5
2024 Q4	1	-
2024 Q3	2	18

TERN Ownership FAQ

Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals shareholders are primarily institutional investors at 90.74%, followed by 0.30% insiders and 8.96% retail investors. The average institutional ownership in Terns Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Terns Pharmaceuticals falls below.

Who owns the most shares of Terns Pharmaceuticals?

Terns Pharmaceuticals’s largest shareholders are Soleus capital management (8.17M shares, 8.92%), Orbimed advisors (7.56M shares, 8.26%), and Deep track capital, lp (7.5M shares, 8.18%). Together, they hold 25.36% of Terns Pharmaceuticals’s total shares outstanding.

Does Blackrock own Terns Pharmaceuticals?

Yes, BlackRock owns 5.53% of Terns Pharmaceuticals, totaling 4.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 28.06M$. In the last quarter, BlackRock increased its holdings by 804.98K shares, a 24.28% change.

Who is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.68% of its assets in 1.29M Terns Pharmaceuticals shares, valued at 4.8M$.

Who is the top mutual fund holder of Terns Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Terns Pharmaceuticals shares, with 2.43% of its total shares outstanding invested in 2.12M Terns Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools